Mandatory Controlled Substance Prescribing

Ongoing through Thursday, January 31, 2019, 4am Controlled Substance Prescribing - The required course for DEA-registered prescribers in Florida. It is no secret that Florida is currently in the grip of a severe opioid crisis. According to a 2017 report by the Florida Department of Law Enforcement, opioids were identified as either the cause of death or were present in the decedent's system in 5,725 cases in 2016. That's 1,483 more than 2015. There have been indications that opioid overdoses claim at least 16 Florida residents per day. On March 19, 2018, Gov. Rick Scott signed into law bill HB 21, which includes a variety of measures to combat the crisis. Among other things, the bill states that each person registered with the United States Drug Enforcement Administration and authorized to prescribe controlled substances shall complete a board-approved two-hour continuing education (CE) course on prescribing controlled substances. The Florida Medical Association (FMA) is authorized by HB 21 to provide this two-hour mandatory requirement for MDs and DOs. Although only DEA-registered prescribers of controlled substances are actually required to complete this training every two years, all physicians are welcome to complete the video course. All CME credit earned will be reported to CE Broker. HB 21 requires prescribers to complete this course for the first time no later than January 31, 2019 and then for each subsequent renewal thereafter.

Housing Closes at NOON/Commencement participant

Friday, December 14, 2018, 12am – 11:59pm Housing Closes at NOON/Commencement participant

Update on Neurology of Women 2018: Gender Differences in Treating Neurologic Disease

Friday, December 14, 2018, 7am – 3:30pm       COURSE OVERVIEW This course will educate learners regarding best practices when caring for women with neurologic disease and will focus on sex and gender differences of neurological conditions across all stages of womens' lives - from menarche through menopause, including pregnancy. The course will present the appropriate gender-based considerations in epilepsy, multiple sclerosis, stroke, migraine and neuropathies. High quality, leading-edge presentations will provide evidence-based clinical approaches and up-to-date research on women’s health and gender-specific care in neurology. Interactive learning formats include panel discussions, case-based presentations and Q&A, allowing learners to engage in the educational process   EDUCATIONAL OBJECTIVES Upon completion of this activity, participants should be able to: Appraise the presentation, clinical course and treatment options for Stroke in women across their lifespan Compare the multidirectional interactions between female sex steroid hormones, Epilepsy and antiepileptic drugs Analyze the safety and management of prescribing medications for the treatment of Multiple Sclerosis during pregnancy Evaluate the diagnosis and management of menstrual Migraine, and migraine in pregnancy and menopause as well as review the drug safety profiles in lactation and pregnancy of migraine medications Evaluate the diagnosis and management of neuropathies and neuromuscular junction disorders with special consideration on gender and pregnancy.    TARGET AUDIENCE Neurologists Psychiatrists Internists Family Physicians Obstetricians Nurses and Nurse Practitioners Physician Assistants  Fellows and Residents   SERVICES FOR THE DISABLED Please contact the Division of CME prior to December 1, 2018 should you have any special needs that may require additional assistance. A conference staff member will contact you to discuss these special requirements.  FOR MORE INFORMATIONFeel free to contact: Division of Continuing Medical Education Tel: 305-243-6716 / Fax: 305-243-5613 cme@med.miami.edu REGISTRATION FEES**<table style="border-width: 1px; border-color: #000000; border-image: initial; top: 46px; width: 597px; height: 370px; left: 28px;" border="0" cellspacing="0" cellpadding="0" align="center"><tbody><tr style="height: 30pt;"><td class="xl64" style="height: 30pt; width: 186pt;">TUITION</td><td class="xl65" style="width: 48pt; text-align: center;">Before 11/14/2018</td><td class="xl65" style="width: 48pt; text-align: center;">As of 11/14/2018</td><td class="xl66" style="width: 48pt; text-align: center;"> Onsite</td></tr><tr style="height: 15pt;"><td style="height: 15pt;">Physicians</td><td class="xl63" style="text-align: center;">$225</td><td class="xl63" style="text-align: center;">$300</td><td class="xl63" style="text-align: center;">$425</td></tr><tr style="height: 15pt;"><td style="height: 15pt;">Residents/Fellows (Non-UM)</td><td class="xl63" style="text-align: center;">$100</td><td class="xl63" style="text-align: center;">$150</td><td class="xl63" style="text-align: center;">$200</td></tr><tr style="height: 15pt;"><td style="height: 15pt;">Physician…

Dialogues in Research Ethics: Medicine in the Era of the All of Us Research Program

Friday, December 14, 2018, 12 – 1pm UM Ethics Programs will hold its monthly Dialogues in Research Ethics seminar on Friday, December 14, from noon to 1 p.m., at the Mailman Center for Child Development, Room 5003. Stephan Züchner, M.D., Ph.D., professor and chair of the Dr. John T. Macdonald Foundation Department of Human Genetics, professor of neurology, and co-director of the John P. Hussman Institute for Human Genomics, will present "Medicine in the Era of the All of Us Research Program." Genetic research is increasingly organized in large-scale consortia. This has advantages — and poses a number of interesting and important ethical challenges. These include the creation and use of very large bio- and data repositories, managing incidental findings, and the task of establishing and sustaining trust among study participants. The All of Us Research Program is the largest such project ever undertaken by the National Institutes of Health and will shape biomedical science for the next decade and beyond. This presentation will provide an overview of the project, describe UM’s role in the partnership, and address a number of the ethical issues raised by the collaboration. Lunch will be provided; first come, first served. For more information, contact UM Ethics Programs at 305-243-5723 or ethics@miami.edu.

Housing Closes for Commencement Participants

Friday, December 14, 2018, 12pm Housing Closes at NOON for Commencement Participants

Calendar